women with NMOSD

Prevalence of disease for NMOSD estimated at 22,000 US patients

A new study of disease prevalence estimates that about 22,000 people in the U.S. were living with neuromyelitis optica spectrum disorder (NMOSD) in 2022. The findings also suggest that the progressive autoimmune disease is most common in Black women, as compared with other U.S. demographics. For Asian American women,…

ACTRIMS 2023: NMOSD affects 3 times more women than men in US

The annual prevalence of neuromyelitis optica spectrum disorder (NMOSD) in the U.S. is considerably higher than previously estimated, affecting about nine out of every 100,000 people, according to a study that analyzed 2021 electronic health records. The data also showed that the disease is more than twice as common…

Postpartum Women at Risk of NMOSD Onset, Rebound: Study

Women are more likely to have neuromyelitis optica spectrum disorder (NMOSD) symptoms, or a rebound of symptoms, within three months after delivering a baby, a Chinese study found. Women who didn’t receive immunotherapy during pregnancy and the postpartum period were more than five times as likely to have…

ESR1 Gene Variations More Common in Women With NMOSD: Study

Certain variations in the ESR1 gene — a protein-coding gene for estrogen receptor-alpha — are significantly more common among women with neuromyelitis optica spectrum disorder (NMOSD) or multiple sclerosis (MS) than among healthy women, a small study suggests. Such differences were not observed between men with these…